Back to Search
MARK EPSTEIN, MD
MD
Neurology with Special Qualifications in Child Neurology Physician
NPI: 1376613430Individual
Specialties, Licenses & Credentials
Neurology with Special Qualifications in Child Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology with Special Qualifications in Child Neurology
Code: 2084N0402X
ME0057002(FL)
Research & Publications (20)
Re-examining RAS-blocking treatment regimens for abrogating progression of chronic kidney disease.
PMID 18981997·Nat Clin Pract Nephrol·2009
8-other
John P. Merrill: the father of nephrology as a specialty.
PMID 19129319·Clin J Am Soc Nephrol·2009
8-other
The role of aldosterone in resistant hypertension: implications for pathogenesis and therapy.
PMID 17442219·Curr Hypertens Rep·2007
6-review
Resistant hypertension: prevalence and evolving concepts.
PMID 17215648·J Clin Hypertens (Greenwich)·2007
6-review
Atorvastatin does not induce glomerular or tubular dysfunction even at high doses.
PMID 17786079·J Cardiometab Syndr·2007
4-observational
Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
PMID 17699311·Clin J Am Soc Nephrol·2006
4-observational
Aldosterone blockade: an emerging strategy for abrogating progressive renal disease.
PMID 17071154·Am J Med·2006
6-review
Adding spironolactone to conventional antihypertensives reduces albuminuria in patients with diabetic nephropathy.
PMID 16932450·Nat Clin Pract Nephrol·2006
8-other
The Self-Report Psychopathy Scale and passive avoidance learning: a validation study of race and gender effects.
PMID 16672734·Assessment·2006
4-observational
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors on renal function.
PMID 15696439·Am J Kidney Dis·2005
6-review
Evolving role of calcium antagonists in the management of hypertension.
PMID 14871057·Med Clin North Am·2004
6-review
Role of aldosterone blockade in the management of hypertension and cardiovascular disease.
PMID 15248358·Contrib Nephrol·2004
6-review
Aldosterone receptor blockade and the role of eplerenone: evolving perspectives.
PMID 13679471·Nephrol Dial Transplant·2003
4-observational
Evolving therapeutic strategies for retarding progression of diabetic nephropathy--an update for 2002.
PMID 12222627·Acta Diabetol·2002
6-review
Recent landmark clinical trials: how do they modify the therapeutic paradigm?
PMID 12121010·Am J Hypertens·2002
6-review
Non-steroidal anti-inflammatory drugs and the continuum of renal dysfunction.
PMID 12683423·J Hypertens Suppl·2002
6-review
Aldosterone and the hypertensive kidney: its emerging role as a mediator of progressive renal dysfunction: a paradigm shift.
PMID 11393664·J Hypertens·2001
6-review
Aldosterone as a mediator of progressive renal disease: pathogenetic and clinical implications.
PMID 11273866·Am J Kidney Dis·2001
6-review
What is the optimal strategy to intensify blood pressure control and prevent progression of renal failure?
PMID 11551378·Curr Hypertens Rep·2001
6-review
Aldosterone as a mediator of progressive renal dysfunction: evolving perspectives.
PMID 11506295·Intern Med·2001
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2900 S COMMERCE PARKWAY
WESTON, FL 33331 - Phone
- (954) 385-6276
Quick Facts
- NPI
- 1376613430
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile